These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20621105)

  • 1. Functional evidence for a twisted conformation of the NMDA receptor GluN2A subunit N-terminal domain.
    Stroebel D; Carvalho S; Paoletti P
    Neuropharmacology; 2011 Jan; 60(1):151-8. PubMed ID: 20621105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N-terminal domains of both NR1 and NR2 subunits determine allosteric Zn2+ inhibition and glycine affinity of N-methyl-D-aspartate receptors.
    Madry C; Mesic I; Betz H; Laube B
    Mol Pharmacol; 2007 Dec; 72(6):1535-44. PubMed ID: 17878266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of NMDA receptor functional diversity.
    Paoletti P
    Eur J Neurosci; 2011 Apr; 33(8):1351-65. PubMed ID: 21395862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the intracellular GluN2 C-terminal domain on NMDA receptor function.
    Punnakkal P; Jendritza P; Köhr G
    Neuropharmacology; 2012 Apr; 62(5-6):1985-92. PubMed ID: 22245680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of triheteromeric NMDA receptors by N-terminal domain ligands.
    Hatton CJ; Paoletti P
    Neuron; 2005 Apr; 46(2):261-74. PubMed ID: 15848804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Basis of the Proton Sensitivity of Human GluN1-GluN2A NMDA Receptors.
    Zhang JB; Chang S; Xu P; Miao M; Wu H; Zhang Y; Zhang T; Wang H; Zhang J; Xie C; Song N; Luo C; Zhang X; Zhu S
    Cell Rep; 2018 Dec; 25(13):3582-3590.e4. PubMed ID: 30590034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On mechanism of allosteric modulation of NMDA receptor via amino-terminal domains.
    Karlov DS; Radchenko EV; Zefirov AN; Palyulin VA; Pentkovski VM; Zefirov NS
    Biochem Biophys Res Commun; 2012 Aug; 424(4):687-90. PubMed ID: 22789854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The function of the amino terminal domain in NMDA receptor modulation.
    Huggins DJ; Grant GH
    J Mol Graph Model; 2005 Jan; 23(4):381-8. PubMed ID: 15670959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric interaction between the amino terminal domain and the ligand binding domain of NR2A.
    Zheng F; Erreger K; Low CM; Banke T; Lee CJ; Conn PJ; Traynelis SF
    Nat Neurosci; 2001 Sep; 4(9):894-901. PubMed ID: 11528420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ifenprodil on GluN1/GluN2B N-methyl-D-aspartate receptor gating.
    Bhatt JM; Prakash A; Suryavanshi PS; Dravid SM
    Mol Pharmacol; 2013 Jan; 83(1):9-21. PubMed ID: 23007555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
    Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P
    Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.
    Hackos DH; Lupardus PJ; Grand T; Chen Y; Wang TM; Reynen P; Gustafson A; Wallweber HJ; Volgraf M; Sellers BD; Schwarz JB; Paoletti P; Sheng M; Zhou Q; Hanson JE
    Neuron; 2016 Mar; 89(5):983-99. PubMed ID: 26875626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric signaling and dynamics of the clamshell-like NMDA receptor GluN1 N-terminal domain.
    Zhu S; Stroebel D; Yao CA; Taly A; Paoletti P
    Nat Struct Mol Biol; 2013 Apr; 20(4):477-85. PubMed ID: 23454977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator.
    Khatri A; Burger PB; Swanger SA; Hansen KB; Zimmerman S; Karakas E; Liotta DC; Furukawa H; Snyder JP; Traynelis SF
    Mol Pharmacol; 2014 Nov; 86(5):548-60. PubMed ID: 25205677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA receptor subunits: function and pharmacology.
    Paoletti P; Neyton J
    Curr Opin Pharmacol; 2007 Feb; 7(1):39-47. PubMed ID: 17088105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An alternating GluN1-2-1-2 subunit arrangement in mature NMDA receptors.
    Riou M; Stroebel D; Edwardson JM; Paoletti P
    PLoS One; 2012; 7(4):e35134. PubMed ID: 22493736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric regulation in NMDA receptors revealed by the genetically encoded photo-cross-linkers.
    Tian M; Ye S
    Sci Rep; 2016 Oct; 6():34751. PubMed ID: 27713495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of recombinant GluN1/GluN2A and GluN1/GluN2B N-methyl-D-aspartate receptors by single malt whiskies.
    Otton HJ; Janssen A; Wyllie DJ
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1423-5. PubMed ID: 19909290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Basis for Subtype Specificity and High-Affinity Zinc Inhibition in the GluN1-GluN2A NMDA Receptor Amino-Terminal Domain.
    Romero-Hernandez A; Simorowski N; Karakas E; Furukawa H
    Neuron; 2016 Dec; 92(6):1324-1336. PubMed ID: 27916457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GluN2A and GluN2B NMDA receptors use distinct allosteric routes.
    Tian M; Stroebel D; Piot L; David M; Ye S; Paoletti P
    Nat Commun; 2021 Aug; 12(1):4709. PubMed ID: 34354080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.